Page last updated: 2024-10-20

phosphorylethanolamine and Fibromyalgia

phosphorylethanolamine has been researched along with Fibromyalgia in 1 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Fibromyalgia: A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sprott, H1
Rzanny, R1
Reichenbach, JR1
Kaiser, WA1
Hein, G1
Stein, G1

Other Studies

1 other study available for phosphorylethanolamine and Fibromyalgia

ArticleYear
31P magnetic resonance spectroscopy in fibromyalgic muscle.
    Rheumatology (Oxford, England), 2000, Volume: 39, Issue:10

    Topics: Adenosine Triphosphate; Adult; Ethanolamines; Female; Fibromyalgia; Glycerylphosphorylcholine; Human

2000